But what about the commitments he's getting in return about investment in America from Apple, from foreign companies, in part to avoid the tariffs, but also just encouraging all of this investment and manufacturing. So, do you think Apple's not acting in its own self-interest. I'm sure I'm sure it is. And I'm nothing against Tim Cook.I mean, Tim Cook's doing what he as CEO should do visav his shareholders. But when the state becomes involved in picking winners and losers, there's only one way this game ends ...

With over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conservative approach sets it apart, consistently unearthing undervalued assets within the realms of ETFs, commodities, technology, and pharmaceutical companies.Allka Research's journey in the investment landscape is marked by a commitment to delivering substantial returns and strategic insights to its clients. In a world filled with complexities, Allka Re ...

Does my heart good to know there's very likely someone out there who nailed the bottom on ETH in April and rotated a decent chunk of those winnings into ASTER and will safely 2x all of that on XPLThere's still so many ways to win, even with big size on majors. Best industry ...

How an asset manager handles climate risk is playing an increasingly important role in the choices that European institutional investors make when assigning mandates, according to an Amundi executive https://t.co/JNOvwGrmvE ...

The UK needs to attract global talent to help support the Labour government’s growth mission, especially after the US raised visa fees for foreign workers, according to Britain’s Investment Minister https://t.co/g5nqQjw4wa ...

Just over four months have passed since the publication of my last article , "Why Investors Should Watch Teva Despite Regional Risks," and during that time, the Teva Pharmaceutical Industries Limited (NYSE: TEVA ) share priceWith over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conservative approach sets it apart, consistently unearthing undervalued assets within the realms of ETFs, commodities, technology, a ...

About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...

CP Group has invested more than $2 billion in the Philippines, building up its presence after setting up a feed mill in the country in 2010. https://t.co/63tuXJNZfY ...

Just over four months have passed since my last article on AstraZeneca (NASDAQ: AZN ) (OTCPK: AZNCF ) "Why AstraZeneca May Be 2025's Most Underrated Pharma Stock," and during that time, its share price has risen 6%.With over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conservative approach sets it apart, consistently unearthing undervalued assets within the realms of ETFs, commodities, technology, and pharmac ...

Silicon Valley is becoming more incestuous than ever. Just days after Nvidia announced a $5bn investment in Intel, its proposed partnership with OpenAI is yet more eye-popping https://t.co/3nHfYC4Jap ...